QUOTE AND NEWS


 
TOP CONTRIBUTORS

iMedicor is a full service network platform / portal for the healthcare sector which includes the features outlined below, summarized in video format at the Company’s YouTube channel.

1.) an online social media / referral network for physicians, healthcare professionals, and patients to share personal health information

2.) free HIPAA-compliant email, secure messaging services for small and large clinics as well as hospitals

3.) an integration driver for use with Electronic Medical Records (EMR) and Personal Health Records, which currently exist largely on a stand-alone basis with incompatible technology platforms and an inability to communicate with each other

4.) free accredited CME courses for healthcare professionals to meet their continuing education requirements and stay informed with new product / device approvals and treatment options (such as the MuGard deal announced today with Access)

iMedicor offers a HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to physicians, healthcare providers, and patients. The iMedicor portal operates via secure messaging specifically designed to compliment clinical workflow, and it meets the requirement of President Obama’s plan for an interoperable health information infrastructure and the conversion of all medical files from paper to electronic records by 2015. Using iMedicor, health information can be exchanged across disparate Electronic Health Records (EHR) systems to communicate, collaborate, and exchange medical records for referrals and patient communications.

The Company’s business model is established on the three core strengths of its network, including:

1.) Physician Network: iMedicor has access to over 95% of physicians in the U.S., representing approximately 730,000 doctors and an associated 1.5 million support staff.

2.) Ease of Use and Level of Security: iMedicor’s network provides complete seamless / encrypted interoperability between disparate EHR systems and provides full HIPAA-compliant security for encrypted document transmission – representing a disruptive technology with the potential to bring about much needed changes and improvements to the current system of EHRs which are not connected and do not communicate with each other.

3.) Medical / Social Networking: The network is designed as a physician-centric social network that is similar to Facebook or LinkedIn with a growing feature set of programs / applications that make it attractive to physicians. In addition, the portal / applications will be made available this fall on handheld devices with voice activation software. iMedicor also offers a full range of social networking services, specifically designed to support physicians such as specialized emails, advertising, blogging with peers, and referral network-building.

iMedicor’s network also offers access to the nation’s largest prescription refill service through a partnership with eRxNetwork which will be available over handhelds this fall and expanded to include e-prescribing and additional prescription networks. In addition, the Company’s network includes a unique video library and a full-service CME offering.

iMedicor expects to make money by providing targeted marketing to this physician network for selected products from medical device / diagnostic and bio-pharmaceutical companies while also providing point-of-care disease management / medication adherence messaging on behalf of health insurance plans, pharmacy benefits managers and pharmaceutical companies. iMedicor can target specific physicians and deliver focused messages and content in an unobtrusive manner from a trusted source. The message content will offer a complete range of action items for the product being advertised while providing the physician with flexibility with regard to accessing the information presented and then measuring the outcomes / responses in real-time.

To date, there have been no internet based advertising programs that have produced an acceptable ROI to the industry and iMedicor expects to change this while targeting a significant market opportunity in the tens of billions of dollars for pharmaceutical advertising. The revenue model for iMedicor will be transaction-based or revenue-sharing with cash flow from early advertising models expected to begin during early 4Q09.

On 9/30/09, iMedicor announced the successful completion of the pilot project of its first direct-to-pharmacy, electronic prescription refill technology via its HIPAA-compliant information exchange portal. Following the successful launch, all 225 of the pilot pharmacy’s outlets went live, well ahead of the projected schedule. This service is free to both the participating physician and pharmacy members of the iMedicor portal to eliminate the manual process of faxing prescription renewal requests and errors associated with handwritten prescription forms while expediting the process of obtaining refills for patients.

In mid-September, iMedicor and Transgenomic (OTC: TBIO.OB) announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease. The alerts-based Internet program will target neurologists, gerontologists and primary care physicians to announce the commercial launch of Transgenomic’s NuroPro assays for these devastating neurological diseases.

In late August, iMedicor announced that it entered a partnership with PhoneTag, the leader in voicemail-to-text services and visual voicemail applications. Through this partnership, physicians and healthcare providers will have access to transcription services on their mobile device of choice. The basic service will be free to all users with a premium monthly subscription upgrade available.

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki